Are statins toxic or safe for kidney diseases? An updated mini-review study
Statins, as the most important cholesterol-lowering agents, inhibit the production of blood cholesterol by blocking an enzyme called the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-COA) reductase. Statins have beneficial effects in some tissues during various injuries. Recent evidence suggests that u...
Saved in:
Main Authors: | Shadi Botshekan (Author), Banafsheh Yalameha (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helicobacter pylori infection and serum magnesium in kidney disease; current concepts
by: Banafsheh Yalameha, et al.
Published: (2020) -
Impact of vitamin D deficiency on health with regard to kidney disease; an updated mini-review
by: Nozar Dorestan, et al.
Published: (2018) -
Antioxidant therapy to improve or resolve atherosclerosis; new hopes and current trends
by: Banafsheh Yalameha
Published: (2019) -
Administration of N-acetylcysteine for contrast-induced acute kidney injury; an updated mini-review
by: Sam Mirfendereski, et al.
Published: (2024) -
Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
by: Mei Tang, et al.
Published: (2021)